Paweł Różanowski

533 total citations
7 papers, 22 citations indexed

About

Paweł Różanowski is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Paweł Różanowski has authored 7 papers receiving a total of 22 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Oncology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Paweł Różanowski's work include Monoclonal and Polyclonal Antibodies Research (2 papers), Glycosylation and Glycoproteins Research (1 paper) and Cancer Mechanisms and Therapy (1 paper). Paweł Różanowski is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (2 papers), Glycosylation and Glycoproteins Research (1 paper) and Cancer Mechanisms and Therapy (1 paper). Paweł Różanowski collaborates with scholars based in Poland, Czechia and South Korea. Paweł Różanowski's co-authors include Dawid Sigorski, Małgorzata Kowalska, Kamil Fijorek, Waldemar Placek, Mirosława Püsküllüoğlu, Barbara Jarząb, Agnieszka Owczarczyk‐Saczonek, Michał Jarząb, Lidia Rudnicka and Katarzyna Wiktorska and has published in prestigious journals such as Targeted Oncology, Współczesna Onkologia and PubMed.

In The Last Decade

Paweł Różanowski

6 papers receiving 22 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Paweł Różanowski Poland	4	10	7	6	3	3	7	22
Marivic Ricamara United Kingdom	2	10 1.0×	8 1.1×	8 1.3×	2 0.7×	2 0.7×	2	16
Osman Mahamud Canada	1	7 0.7×	7 1.0×	11 1.8×	2 0.7×	3 1.0×	2	20
Suellen Rodrigues Rangel Siqueira Brazil	2	9 0.9×	4 0.6×	8 1.3×	2 0.7×	1 0.3×	3	35
Leo Arribas Spain	2	4 0.4×	5 0.7×	7 1.2×	4 1.3×		2	19
Elisabeth Wimmer Austria	2	8 0.8×	7 1.0×	3 0.5×	3 1.0×		3	15
Д. Г. Шахматов Russia	3	9 0.9×	3 0.4×	3 0.5×	4 1.3×	2 0.7×	17	18
Hugo Hool United States	2	18 1.8×	3 0.4×	6 1.0×	2 0.7×		3	20
Kristina Brennan United States	2	7 0.7×	3 0.4×	4 0.7×	1 0.3×	2 0.7×	3	11
Rachel Chernet United States	3	6 0.6×	3 0.4×	9 1.5×	2 0.7×	1 0.3×	4	19
Sarah Nuyens Belgium	3	6 0.6×	7 1.0×	5 0.8×		1 0.3×	5	24

Countries citing papers authored by Paweł Różanowski

Since Specialization

Citations

This map shows the geographic impact of Paweł Różanowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paweł Różanowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paweł Różanowski more than expected).

Fields of papers citing papers by Paweł Różanowski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paweł Różanowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paweł Różanowski. The network helps show where Paweł Różanowski may publish in the future.

Co-authorship network of co-authors of Paweł Różanowski

This figure shows the co-authorship network connecting the top 25 collaborators of Paweł Różanowski. A scholar is included among the top collaborators of Paweł Różanowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paweł Różanowski. Paweł Różanowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Sigorski, Dawid, Paweł Różanowski, Ewa Iżycka‐Świeszewska, & Katarzyna Wiktorska. (2022). Antibody–Drug Conjugates in Uro-Oncology. Targeted Oncology. 17(3). 203–221. 4 indexed citations

2.

Jahnz‐Różyk, Karina, Marek Brzosko, Ewa Lech‐Marańda, et al.. (2019). The Polish Expert Group Position Statement on the Safety of Biological Treatments with Monoclonal Antibodies and Fusion Proteins: An Update. 9–9. 1 indexed citations

3.

Sigorski, Dawid, et al.. (2019). Complete pathological remission after palliative therapy with sorafenib in hepatocellular carcinoma — case report. Oncology in Clinical Practice. 15(2). 127–131. 1 indexed citations

4.

Owczarczyk‐Saczonek, Agnieszka, et al.. (2017). Cutaneous manifestations of breast cancer. Dermatology Review. 5. 561–569. 5 indexed citations

5.

Fijorek, Kamil, et al.. (2013). HER-3 expression in HER-2-amplified breast carcinoma. Współczesna Onkologia. 5(5). 446–449. 4 indexed citations

6.

Różanowski, Paweł, et al.. (2010). Ocena wartości prognostycznej i predykcyjnej 21 genowego wskaźnika ryzyka nawrotu nowotworu (recurrence score) we wczesnym raku piersi. Doniesienie wstępne. Nowotwory Journal of Oncology. 60(5). 433–433.

7.

Jarząb, Michał, et al.. (2008). Optimization of the method of RNA isolation from paraffin blocks to assess gene expression in breast cancer.. PubMed. 59(2). 85–91. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact